| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $289.4M | -6.9% |
| R&D Expense | $67.7M | -3.7% |
| SG&A Expense | $46.1M | +2.3% |
| Operating Income | -$32.9M | -213.4% |
| Pre-tax Income | -$27.3M | -982.9% |
| Income Tax | $1.4M | -91.7% |
| Net Income | -$28.7M | -47.9% |
| EPS (Basic) | -$0.22 | -46.7% |
| EPS (Diluted) | -$0.22 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.2M | -17.8% |
| Current Assets | $147.1M | -15.9% |
| Total Assets | $323.0M | -11.8% |
| Current Liabilities | $49.4M | +7.4% |
| Total Liabilities | $78.2M | +0.3% |
| Stockholders' Equity | $244.7M | -15.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $45.7M | -11.6% |
| Capital Expenditures | $4.0M | -37.2% |
| Investing Cash Flow | -$26.3M | +18.6% |
| Financing Cash Flow | -$41.9M | -107.7% |
| Free Cash Flow | $41.8M | -8.0% |
| -46.7% |